Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

You searched for:

ASCO® DIRECT Highlights 2019: Gynecologic Cancers Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 30 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene …
Legislating Patients' Rights Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Legislating Patients' Rights Jamie Young To cite this article: Jamie Young (1998) Legislating …
SO06-Legal-Corner
MA06-Editor
American Society for Therapeutic Radiology and Oncology 2001 American Society for Therapeutic Radiology and Oncology by David Hussey, M.D. WHO WE ARE T he American Society for T herapeuti c Radiology and O ncology (AST RO) was fou nded in \958 to promote the practice of radia tion oncology . With a membership of 6.200. AST RO's mission is 10 advance the practice of radiat io n cncol- ogy …
The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the multidisciplinary cancer team. ACCC is a powerful network of 24,000 cancer care professionals from 2,100 hospitals and practices nationwide. ACCC is recognized as the premier provider of resources for the entire oncology care team. For more information, visit accc-cancer.org or call …
Will Clinical Trials Survive? Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Will Clinical Trials Survive? Carl G. Kardinal To cite this article: Carl G. Kardinal (1995) Will Clinical …
Barbara L. McAneny, MD, FASCO, MACP, a board-certified medical oncologist/hematologist from Albuquerque, NM, became the 173rd president of the American Medical Association (AMA) in June 2018, serving as its chair in 2015–2016. Dr. McAneny is a fellow and former member of the board of directors of the American Society of Clinical Oncology (ASCO), a master of the American College of Physicians, and a …
SO10-NxBbook
Implementation of an Electronic Clinical Management System: One Cancer Center's Experience Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Implementation of an Electronic Clinical Management …
Updated PDF with Ads.pdf C o-pay card programs are designed to make it easy for patients to use awarded funds and apply those funds to patient balances resulting from deductible or co-insurance amounts due that must be met before insurance pays 100 percent. To participate in a co-pay card program, patients apply (by phone, online, or via faxed applications) to the participating …
Microsoft Word - 8637517_7 EXECUTIVE OFFICE: 11600 Nebel Street. Suite 201. Rockville, MD 20852-2557. Phone: 301.984-9496. Fax: 301-770-1949 www.accc-cancer.org \\DC - 099654/000003 - 8637517 v7 OFFICERS President Jennie R. Crews, MD, MMM, FACP PeaceHealth St. Joseph Medical Center St. Joseph Cancer Center Bellingham, Washington President-Elect Mark S. Soberman, MD, MBA, FACS Monocacy …
JF11-Profile
SO11-Tools
SO15-Tools
65 OI | Vol. 38, No 6, 2023 | accc-cancer.org spotlight Highlands Oncology North Arkansas A s the only diamond producing state in the United States, Arkansas is home to many gems. Among them is one of the largest physician-owned cancer programs in the country—Highlands Oncology. Estab- lished in 1996, the founding physicians sought to bring comprehensive cancer care to Northwest …
12 accc-cancer.org | Vol. 37, No. 4, 2022 | OI Approved Drugs • On April 18, the U.S. Food and Drug Administration (FDA) approved Alymsys® (bevacizumab-maly) (Brand Institute and mAbxience, brandinstitute.com and mabxience.com)—a biosimilar to Avastin® (bevacizumab). Alymsys’s approved indications include: 1) metastatic colorectal cancer in combination with intravenous fluorouracil-based …
FY19 Monthly Operating review (MOR) (Place Business, Site and Name here) CREATED BY: RIFETA KAJDIC ONCOLOGY PROGRAM MANAGER MARCH 2020 ONCOLOGY PATIENT FINANCIAL ADVOCATE TRAINING OVERVIEW Cancer Institute Oncology PFA Learning Pathway About Us Getting Started Navigating TEAMS Cancer Resources Documentation Inbaskets Medical Necessity Episode …
20 accc-cancer.org | Vol. 37, No. 1, 2022 | OI Approved Drugs • On Nov. 12, the U.S. Food and Drug Administration (FDA) approved Besremi® (ropeginterferon alfa-2b-njft) (PharmaEssentia Corporation, us. pharmaessentia.com) for the treatment of adults with polycythemia vera. • On Nov. 29, the FDA approved Cytalux™ (pafolacianine) (On Target Laboratories, Inc., ontargetlabs.com) as an …
Resurrection Medical Center Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Resurrection Medical Center Streamlining Patient Care To cite this article: (1996) Resurrection Medical …